VECO vs VRTX · P/E 199, rev $351.8M vs P/E 30, rev $3.33B
Veeco Instruments Inc (VECO) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Veeco Instruments Inc (VECO) is a semiconductor equipment & materials company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported VECO revenue for 2026-06-30 was $351.8M. Net income was $11.5M. VECO currently screens at market cap $4.63B and trailing P/E 199.4.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
VECO currently screens at market cap $4.63B and trailing P/E 199.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the VECO and VRTX stock pages for the full models.
Not investment advice.